TiGenix: TiGenix and Lonza sign agreement for the manufacture of stem cell … – GlobeNewswire (press release)
|
TiGenix: TiGenix and Lonza sign agreement for the manufacture of stem cell …
GlobeNewswire (press release) Cx601 is a locally-injected suspension of allogeneic expanded adipose-derived stem cells (eASCs) for the treatment of complex perianal fistulas in Crohn's disease patients, currently in Phase 3 of clinical development in Europe. Following the positive … |
